Insight

Steven Wexner: Medical Therapies to Prevent Relapse of Crohn’s Disease After Surgery

Hassan R. Hashmi and Steven Wexner

Aug 22, 2025, 12:31

Steven Wexner: Medical Therapies to Prevent Relapse of Crohn’s Disease After Surgery

Steven Wexner, Editor In Chief at Surgery, shared on X about a recent paper by Rachel Gefen et al. published on ScienceDirect:

“Medical therapies to prevent relapse of Crohn’s disease after surgery..”

Title: Medical therapies to prevent relapse of Crohn’s disease after surgery: A systematic review and network meta-analysis

Authors: Rachel Gefen, Shani Y. Parnasa, Sameh Hany Emile, Nir Horesh, Justin Dourado, Zoe Garoufalia, Anjelli Wignakumar, Marylise Boutros, Steven D. Wexner

Read the full article.

Steven Wexner

Hassan R. Hashmi, General and Colorectal Surgeon at LVSA, shared Steven D Wexner’s post:

“PRISMA-compliant systematic review & network meta-analysis on Crohn’s recurrence post-surgery: adalimumab ranked highest, infliximab second. Both reduced recurrence vs placebo, though adalimumab had higher severe AE risk. Key data for risk–benefit decisions.”

More posts featuring Steven D. Wexner and Hassan R. Hashmi.

Anjelli Wignakumar cancer Crohn's disease Hassan R. Hashmi Justin Dourado Marylise Boutros Nir Horesh OncoDaily Oncology Rachel Gefen Sameh Hany Emile Shani Y. Parnasa Steven D. Wexner Zoe Garoufalia

FDA has Granted Full Market Approval for Papzimeos - NIH

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

Weight Loss Trial Reports Success for Breast Cancer Patients at One Year Mark

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer